Women are not the same as men: Specific clinical issues for female patients with bipolar disorder

Bipolar Disorders, Supplement

Volumn 7, Issue 1, 2005, Pages 16-24

  Curtis, Vivienne ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antipsychotic medication; Bipolar disorder; Gender; Mood stabilizers; Pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOZAPINE; FOLIC ACID; HALOPERIDOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID;

AGITATION; AKATHISIA; BIPOLAR DISORDER; BIPOLAR II DISORDER; BONE DENSITY; BREAST FEEDING; CARDIOTOXICITY; CHILD REARING; CLINICAL FEATURE; COMORBIDITY; CONTRACEPTION; CYANOSIS; DEPRESSION; DEVELOPMENTAL DISORDER; DIZZINESS; DRUG DOSE REGIMEN; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ELECTROCONVULSIVE THERAPY; EPILEPSY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FEMALE INFERTILITY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART MURMUR; HERITABILITY; HUMAN; HYPERANDROGENISM; HYPERPROLACTINEMIA; HYPERSALIVATION; HYPOTENSION; INSOMNIA; LACTATION; LETHARGY; LEUKOPENIA; LIFE EVENT; MEDICAL DECISION MAKING; MENSTRUATION DISORDER; MUSCLE HYPOTONIA; NAUSEA; NEURAL TUBE DEFECT; OSTEOLYSIS; OVARY POLYCYSTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; RAPID CYCLING BIPOLAR DISORDER; REVIEW; SEDATION; SEIZURE; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TERATOGENICITY; TREATMENT INDICATION; TREMOR; WEIGHT GAIN; XEROSTOMIA;

EID: 26444480737     PISSN: 13992406     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2005.00190.x     Document Type: Review

References (77)

1. Leibenluft E. Women with bipolar illness: clinical and research issues. Am J Psychiatry 1996; 153: 163-173.
2. Leibenluft E. Women and bipolar disorder: an update. Bull Menninger Clin 2000; 64: 5-17.
3. Hendrick V, Altshuler LL, Gitlin MJ, Delrahim S, Hammen C. Gender and bipolar illness. J Clin Psychiatry 2000; 61: 393-396.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, revised (DSM-IV). Washington, DC: American Psychiatric Press, 1994.
5. Hirschfeld RM, Calabrese JR, Weissman MM et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64: 53-59.
6. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159 (Suppl.): 1-50.
7. Judd L, Akiskal H, Schettler P. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 56: 530-537.
8. McElroy SL, Keck PE, Jr, Pope HG, Jr, Hudson JI, Faedda GL, Swann AC. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992; 149: 1633-1644.
9. Arnold LM, McElroy SL, Keck PE, Jr. The role of gender in mixed mania. Compr Psychiatry 2000; 41: 83-87.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text Revision Edition. Washington, DC: American Psychiatric Association, 2000.
11. Calabrese JR, Shelton MD, Rapport DJ, Kujawa M, Kimmel SE, Caban S. Current research on rapid cycling bipolar disorder and its treatment. J Affect Disord 2001; 67: 241-255.
12. Barrios C, Chaudhry TA, Goodnick PJ. Rapid cycling bipolar disorder. Expert Opin Pharmacother 2001; 2: 1963-1973.
13. Grunze H, Amann B, Dittmann S, Walden J. Clinical relevance and treatment possibilities of bipolar rapid cycling. Neuropsychobiology 2002; 45 (Suppl. 1): 20-26.
14. Post RM, Denicoff KD, Leverich GS et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 2003; 64: 680-690; quiz 738-739.
15. Salloum IM, Thase ME. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord 2000; 2: 269-280.
16. Frye MA, Altshuler LL, McElroy SL et al. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry 2003; 160: 883-889.
17. Salloum IM, Cornelius JR, Mezzich JE et al. Characterizing female bipolar alcoholic patients presenting for initial evaluation. Addict Behav 2001; 20: 341-348.
18. Hyun M, Friedman SD, Dunner DL. Relationship of childhood physical and sexual abuse to adult bipolar disorder. Bipolar Disord 2000; 2: 131-135.
19. Coverdale JH, Turbott SH. Sexual and physical abuse of chronically ill psychiatric outpatients compared with a matched sample of medical outpatients. J Nerv Ment Dis 2000; 188: 440-445.
20. Coverdale JH, Turbott SH, Roberts H. Family planning needs and STD risk behaviours of female psychiatric out-patients. Br J Psychiatry 1997; 171: 69-72.
21. Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML. A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271: 146-150.
22. Packer S. Family planning for women with bipolar disorder. Hosp Community Psychiatry 1992; 43: 479-482.
23. McAuley JW, Anderson GD. Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet 2002: 41: 559-579.
24. Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs 2002; 16: 263-272.
25. Potash JB, DePaulo JR, Jr. Searching high and low: a review of the genetics of bipolar disorder. Bipolar Disord 2000; 2: 8-26.
26. Duffy A, Grof P, Robertson C, Alda M. The implications of genetics studies of major mood disorders for clinical practice. J Clin Psychiatry 2000; 61: 630-637.
27. Viguera AC, Cohen LS, Bouffard s, Whitfield TH, Baldessarini RJ. Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. Am J Psychiatry 2002; 159: 2102-2104.
28. Altshuler L, Richards M, Yonkers K. Treating bipolar disorder during pregnancy. Curr Psychiatry 2003; 2: 14-26.
29. Isojarvi JI, Rattya J, Myllyla VV et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998; 43: 446-451.
30. Betts T, Yarrow H, Dutton N, Greenhill L, Rolfe T. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy. Seizure 2003; 12: 323-329.
31. Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT. Myllyla VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993; 329: 1383-1388.
32. McIntyre RS, Mancini DA, McCann S, Srinivasan J, Kennedy SH. Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disord 2003; 5: 28-35.
33. O'Donovan C, Kusumakar V, Graves GR, Bird DC. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder. J Clin Psychiatry 2002; 63: 322-330.
34. Compton MT, Miller AH. Antipsycholic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacol Bull 2002; 36: 143-164.
35. Jones EE. Hyperprolactinemia and female infertility. J Reprod Med 1989; 34: 117-126.
36. Smith S, Wheeler MJ, Murray R, O'Keane V. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis. J Clin Psychopharmacol 2002; 22: 109-114.
37. Smith SM, O'Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 2002; 181: 49-55.
38. Viguera AC, Cohen LS, Baldessarini RJ, Nonacs R. Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can J Psychiatry 2002; 47: 426-436.
39. Viguera AC, Cohen LS. The course and management of bipolar disorder during pregnancy. Psychopharmacol Bull 1998; 34: 339-346.
40. Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry 1987; 150: 662-673.
41. Appleby L. Suicide during pregnancy and in the first postnatal year. BMJ 1991; 302: 137-140.
42. Marzuk PM, Tardiff K, Leon AC et al. Lower risk of suicide during pregnancy. Am J Psychiatry 1997; 154: 122-123.
43. Grof P, Robbins W, Alda M et al. Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J Affect Disord 2000; 61: 31-39.
44. Sharma V, Persad E. Effect of pregnancy on three patients with bipolar disorder. Ann Clin Psychiatry 1995; 7: 39-42.
45. Freeman MP, Smith KW, Freeman SA et al. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry 2002; 63: 284-287.
46. Blehar MC, DePaulo JR, Jr, Gershon ES, Reich T, Simpson SG, Nurnberger JI, Jr. Women with bipolar disorder: findings from the NIMH genetics initiative sample. Psychopharmacol Bull 1998; 34: 239-243.
47. Llewellyn A, Stowe ZN, Strader JR, Jr. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry 1998; 59 (Suppl. 6): 57-64; discussion 65.
48. Ernst CL, Goldberg JF. The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics. J Clin Psychiatry 2002; 63 (Suppl. 4): 42-55.
49. Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000: 157: 179-184.
50. Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1993; 50: 448-455.
51. Baldessarini RJ, Tondo L, Viguera AC. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord 1999; 1: 17-24.
52. Samren EB, van Duijn CM, Koch S et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997; 38: 981-990.
53. Yerby MS. Clinical care of pregnant women with epilepsy: neural tube derects and folic acid supplementation. Epilepsia 2003; 44 (Suppl. 3): 33-40.
54. Dunner DL, Patrick V, Fieve RR. Life events at the onset of bipolar affective illness. Am J Psychiatry 1979; 136: 508-511.
55. Brockington IF, Cernik KF, Schofield EM, Downing AR, Francis AF, Keelan C. Puerperal psychosis. Phenomena and diagnosis. Arch Gen Psychiatry 1981; 38: 829-833.
56. Davidson J, Robertson E. A follow-up study of post partum illness, 1946-1978. Acta Psychiatr Scand 1985; 71: 451-457.
57. Schopf J, Rust B. Follow-up and family study of postpartum psychoses. Part I: overview. Eur Arch Psychiatry Clin Neurosci 1994; 244: 101-111.
58. Parry BL. Reproductive factors affecting the course of affective illness in women. Psychiatr Clin North Am 1989; 12: 207-220.
59. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108: 776-789.
60. Sajatovic M, Rosenthal MB, Plax MS, Meyer ML, Bingham CR. Mental illness and menopause: a patient and family perspective. J Gend Specif Med 2003; 6: 31-34.
61. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159: 1-50.
62. Goodwin GM. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003; 17: 149-173; discussion 147.
63. Pope HG, Jr, McElroy SL, Keck PE, Jr, Hudson JI. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry 1991; 48: 62-68.
64. Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry 1982; 39: 1065-1069.
65. Zarate CA, Jr. Antipsychotic drug side effect issues in bipolar manic patients. J Clin Psychiatry 2000; 61 (Suppl. 8): 52-61.
66. Smith S. Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice. J Clin Psychopharmacol 2003; 23: S27-S32.
67. Casey DE. Side effect profiles of new antipsychotic agents. J Clin Psychiatry 1996; 57 (Suppl. 11): 40-45.
68. Garver DL. Review of quetiapine side effects. J Clin Psychiatry 2000; 61 (Suppl. 8): 31-33.
69. Tariot PN, Ismail MS. Use of quetiapine in elderly patients. J Clin Psychiatry 2002; 63 (Suppl. 13): 21-26.
70. McIntyre RS, McCann SM, Kennedy SH. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry 2001; 46: 273-281.
71. Russell JM, Mackell JA. Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications. CNS Drugs 2001; 15: 537-551.
72. Fakhoury WK, Wright D, Wallace M. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. Int Clin Psychopharmacol 2001; 16: 153-162.
73. Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997; 146: 214-222.
74. Willett WC, Manson JE, Stampfer MJ et al. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA 1995; 273: 461-465.
75. Fontaine KR, Heo M, Harrigan EP et al. Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate. Psychiatry Res 2001; 101: 277-288.
76. Wieck A, Haddad PM. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry 2003; 182: 199-204.
77. Bilici M, Cakirbay H, Guler M, Tosun M, Ulgen M, Tan U. Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. Int J Neurosci 2002; 112: 817-828.